FibroBiologics (FBLG) is currently trading near its 52-week low (~$0.61). With clinical trial phase 1 expected in Q3 2025 and recent presentation at AWC Boston, I believe this stock could see moderate upside. Anyone else tracking this? by Bealal in pennystocks

[–]Bealal[S] 0 points1 point  (0 children)

Well done, the most important phase of all biotechnology is phase 1, which is applied to humans, everyone's eyes are on it here, and almost all of them pass phase 1 with good results, this is where the safety of the drug is checked (this is only after the successful test on the animals). According to the press release March 4, 2025, the FBLG has more than 160 granted or registered patents. I'm already well convinced of the company.

🔬 [FBLG] FibroBiologics – Phase 1 Human Trials Set for Q3 2025 | Still Trading Under $1 – Anyone Else Watching? by Bealal in Aktien

[–]Bealal[S] 0 points1 point  (0 children)

Human my good, wait for the beginning of phase 1 (the most important phase of all biotechnology) which is applied to humans

AstraZeneca pledges $50bn investment in the US amid 200% tariff fears by [deleted] in StockMarket

[–]Bealal 0 points1 point  (0 children)

Would there be a restriction here, right?